Applied Therapeutics Inc (NASDAQ:APLT) shares, rose in value on Thursday, January 02, with the stock price up by 4.91% to the previous day’s close as strong demand from buyers drove the stock to $0.90.
Actively observing the price movement in the last trading, the stock closed the session at $0.86, falling within a range of $0.8402 and $0.979. The value of beta (5-year monthly) was 2.018. Referring to stock’s 52-week performance, its high was $10.62, and the low was $0.77. On the whole, APLT has fluctuated by -48.67% over the past month.
With the market capitalization of Applied Therapeutics Inc currently standing at about $104.51 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 100k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that APLT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of APLT currently trading nearly -15.21% and -83.70% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 19.45, while the 7-day volatility ratio is showing 12.61% which for the 30-day chart, stands at 13.37%. Furthermore, Applied Therapeutics Inc (APLT)’s beta value is 1.84, and its average true range (ATR) is 0.33.
A comparison of Applied Therapeutics Inc (APLT) with its peers suggests the former has fared considerably weaker in the market. APLT showed an intraday change of 4.91% in last session, and over the past year, it shrunk by -75.32%%.
Data on historical trading for Applied Therapeutics Inc (NASDAQ:APLT) indicates that the trading volumes over the past 10 days have averaged 6.56 and over the past 3 months, they’ve averaged 5.35 million. According to company’s latest data on outstanding shares, there are 116.36 million shares outstanding.
Nearly 25.56% of Applied Therapeutics Inc’s shares belong to company insiders and institutional investors own 88.02% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 18.15 million shares as on 2024-12-13, resulting in a short ratio of 1.85. According to the data, the short interest in Applied Therapeutics Inc (APLT) stood at 1741.00 of shares outstanding as of 2024-12-13; the number of short shares registered in 2024-11-15 reached 13.56 million. The stock has risen by 4.91% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the APLT stock heading into the next quarter.
